TerminatedNot Applicable

COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)

Stopped: End of covid crisis

France23 participantsStarted 2021-11-05

Plain-language summary

The objective of this research is to build a collection of non-invasive retinal imaging (OCT and OCTA) in order to investigate the incidence and impact of retinal damage in patients who have or have had COVID-19.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years old * Diagnosis of COVID-19 proven on RT-PCR, antigenic test or chest CT scan * Affiliation to the general social security system * A consent signed by the patient Exclusion Criteria: \- Refusal of patient participation

What they're measuring

Retinal damage at inclusion after Covid-19 infection

Timeframe: Up to one week after inclusion

Trial details

NCT IDNCT04881253

SponsorCentre Hospitalier Intercommunal Creteil

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-17

View on ClinicalTrials.gov More Covid19 trials